SPS - Specialist Pharmacy Service
The first stop for professional medicines advice
About
Log in
Register
NHS
Guidance
Guidance
Guidance index
Search Guidance
Guidance by Care Setting
Adults
Care homes
Care of the elderly
Community Health Services
Critical care
Dentistry
Emergency medicine and urgent care
Health and Justice
Neonates
Occupational Health
Paediatrics
Palliative and End of Life Care
Primary Care
Transfer of care
Trusts
Guidance by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Mental health and illness
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Vaccinating
Wounds and injuries
Events
Events
Events index
Search Events
Events by Care Setting
Community Health Services
Health and Justice
Primary Care
Events by Guidance area
Advanced therapy medicinal products
Adverse effects
Aseptic services
Clean rooms
Medication Safety
Patient Group Directions
Preparing
Safety in Pregnancy
Temperature management
Events by Specialty
Cardiovascular system disorders
Endocrine system disorders
Infection and infectious diseases
Mental health and illness
Neurological disorders
Planning
Planning
Planning index
Search Medicines planning
Planning by Care Setting
Transfer of care
Trusts
Planning by Specialty
Eyes and vision
Gastrointestinal disorders
Musculo-skeletal disorders
Neurological disorders
Skin disorders
Training
Training
Training index
Search Training and Development
Publications
Publications
Publications index
Search Publications
Publications by Care Setting
Emergency medicine and urgent care
Health and Justice
Publications by Specialty
Infection and infectious diseases
Neurological disorders
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Tools
Search
Home
Search
Supply
40 results
Applied filters
Supply
Filter
Care Setting
(11)
Adults
(1)
Care homes
(1)
Community Health Services
(3)
Health and Justice
(1)
Paediatrics
(1)
Palliative and End of Life Care
(1)
Primary Care
(1)
Transfer of care
(9)
Trusts
(1)
Guidance
(40)
Administering
(23)
Advanced therapy medicinal products
(2)
Aseptic services
(1)
Clinical trials
(2)
Dosing
(3)
Medication Safety
(3)
Patient Group Directions
(11)
Policy, Commissioning and Managerial
(1)
Preparing
(1)
Prescribing
(8)
Service advice and planning
(4)
Supply
(40)
Unlicensed medicines
(4)
Medicine
(9)
Atomoxetine
(2)
COVID-19 vaccine
(1)
Dexamfetamine
(2)
Diamorphine
(1)
Dulaglutide
(1)
Exenatide
(1)
Guanfacine
(2)
Ketamine
(1)
Liraglutide
(1)
Lisdexamfetamine
(2)
Methylphenidate
(3)
Midazolam
(1)
Mifepristone
(1)
Misoprostol
(1)
Morphine
(1)
Semaglutide
(1)
Thiamine
(2)
Tramadol
(1)
Medicines planning
(2)
Patient Group Direction Planning
(2)
Publications
(1)
Summary advice
(1)
Specialty
(9)
Diabetes
(1)
Endocrine system disorders
(1)
Gastrointestinal disorders
(2)
Mental health and illness
(4)
Nutritional and metabolic disorders
(1)
Obstetrics and gynaecology
(1)
Supply of aseptically Prepared Doses of IMPs Across Legal Boundaries Version 2 October 2019
11 November 2019
·
This document has been developed by the NHS Quality Assurance Committee and National Pharmacy Clinical Trials Advisory Group with input provided by the MHRA Clinical…
Operational Implications of UK Exit from the EU for NHS Clinical Trial Sites
16 September 2022
·
A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
Outsourcing of Storage or Preparation of ATIMPs Across Legal Boundaries
15 November 2022
·
Guidance on the considerations for Pharmacy Clinical Trial Sites outsourcing activities involved in the delivery of ATIMPs
Acute settings and transcribing
22 February 2022
·
Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings
Off-label or unlicensed product use under HMR 2012 exemptions
8 January 2020
·
A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
Prescribing available HRT products
28 April 2022
·
Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
Patient Group Direction use in End of Life Care
10 August 2020
·
Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.
Worked example of assessing the risk of transcribing
22 February 2022
·
Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
Supply and administration of medicines by staff group (P to Z)
2 April 2024
·
Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Legal mechanisms to supply and administer medicines to individuals
24 January 2022
·
The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
1
2
3
4
Next